Ovid Therapeutics (1OT.F) Q2 2025 Earnings

13MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.2
-0.1
0
0.11

Details

Expected EPS
-0.12288931671
Actual EPS
-0.12510820000000003
Surprise EPS
-0
Surprise Percent
+1.81%

Description

Ovid Therapeutics (1OT.F) has reported earnings of -0.12510820000000003 per share for Q2 2025.

0 Comments

Share your thoughts